To show the latest technological advancements in real-time Transrectal Ultrasound (TRUS) fusion imaging for Prostate diagnostics and biopsy real-time guidance.
Prostate cancer is the most common cancer and the second most common cause of cancer deaths among men in the western countries .
The management of prostate cancer is a complex issue because of the difficulty in accurate staging and in predicting the speed of disease progression .
The current methods of prostate cancer detection include digital rectal examination (DRE),
serum prostate-specific antigen (PSA) level and TRUS with random biopsy .
The role of Magnetic Resonance Imaging...
Findings and procedure details
In recent years real-time Ultrasound image fusion with a pre-acquired second imaging dataset has become more common also in prostate diagnosis and biopsy guidance [17,
18]. In our experiences,
real-time fusion imaging was carried out by MyLabTwice Ultrasound system (Esaote S.p.A.,
Italy – Fig.
8) equipped with Virtual Navigator technology. The endocavity probes used were TRT33 and EC1123. TRT33 (Fig.
9) is Transrectal probe with a dual transducer: a Microconvex (6.5MHz center...
In our experience,
real-time Fusion Imaging with Virtual Navigator technology was mainly used in TRUS for Urology application regarding: · Real-time biopsy guidance by the Virtual Biopsy tool,
for needle path visualization in order to target and plan needle path,
using any second imaging modality (MRI,
PET/CT). · Everyday Clinical Practice - fusion imaging technology needs only a slight increase in time in order to be ready for real-time navigation.
With the possibility to use also previously...
Sara D'Onofrio firstname.lastname@example.org
 Jemal A.,
“ Cancer statistics ”,
CA Cancer J Clin2009; 59:225-249.  Hricak H.,
“ MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer ”,
Br J Radiol 2005; 78[Spec No 2]:S103-S111.  A.
“ MRI and ultrasound guided prostate biopsy using the fusion imaging technique ”,
ePOS ECR 2013,
DOI: 10.1594/ecr2013/C-2333. ...